Kaskela Law is investigating the proposed buyout of Surgery Partners, Inc. (NASDAQ: SGRY) shareholders to determine whether the proposed $23.50 per share buyout price undervalues the company’s shares.
On October 26, 2026, Surgery Partners announced that it had agreed to be acquired by HealthSpan Partners at a price of $23.50 per share in cash. Following the closing of the proposed transaction, Surgery Partners’ shareholders will be cashed out of their investment position and the company’s shares will no longer be publicly traded.
The investigation seeks to determine whether Surgery Partners’ investors will be receiving sufficient financial consideration for their shares. Notably, at the time the proposed transaction was announced, numerous stock analysts were maintaining a price target in excess of $28.00 for Surgery Partners’ shares.
Surgery Partners shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) for additional information about their legal rights and options at (484) 229 – 0750, by email at skaskela@kaskelalaw.com or abell@kaskelalaw.com, or by completing the form on this page.